Sana Biotechnology, Inc. Common Stock

€2.715
EUR
Last updated on --.
24h volume623.85K
24h highest2.8013 EUR
24h lowest2.6554 EUR
24h Price movement-0.16%

SANA recent prices

24 Hours
-0.16%-€0.0043445
30 days
-21.28%-€0.73422
60 days
+16.60%+€0.38666
90 days
-14.15%-€0.44748

Key data

Previous close2.7197 EUR
Market cap785.87M EUR
Volume623.85K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-0.75594 EUR
Net income (FY)-210.26M EUR
Revenue (FY)--
Last report dateMay 11, 2026

About Sana Biotechnology, Inc. Common Stock

BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
HeadquartersSEATTLE
Employees (FY)142.00
Net income per employee (FY)-1.48M EUR
Listed onNasdaq
Official website

SANA conversion tables

SANASANA
EUREUR
0.5 SANA1.357 EUR
1 SANA2.715 EUR
5 SANA13.57 EUR
10 SANA27.15 EUR
EUREUR
SANASANA
0.5 EUR0.18414 SANA
1 EUR0.36828 SANA
5 EUR1.841 SANA
10 EUR3.682 SANA

FAQ

SANA is trading at €2.715, -0.16% over the last 24 hours. Track live moves on the price chart at the top of this page.
The SANA stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. SANA is currently trading at €2.715, -0.16% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on SANA price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. SANA's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from SANA; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against SANA's historical range and other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Sana Biotechnology, Inc. Common Stock's market cap is currently 785.87M EUR. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume623.85K
24h highest2.8013 EUR
24h lowest2.6554 EUR
24h Price movement-0.16%
SANASANA
EUREUR
Start trade with SANA Perpetual